Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Name: Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia
Published: 2015
License: Public Domain

Janssen Pharmaceutical K.K. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

alzheimer-s-disease

alzheimer's disease, alzheimer dementia, jnj-54861911, beta secretase inhibitor, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Related documents